Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Clinical trial NCT00546936 · UNKNOWN

Trial details

NCT number: NCT00546936
Sponsor: Barnes Retina Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Presumed Ocular Histoplasmosis (POHS)

Start date: 2007-10-01
Primary completion: 2009-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.